SCHOTT Pharma AG & Co. KGaA (ETR: 1SXP)
Germany
· Delayed Price · Currency is EUR
26.62
+0.40 (1.53%)
Nov 22, 2024, 9:00 AM CET
SCHOTT Pharma AG & Co. KGaA Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 253.59M EUR in the quarter ending June 30, 2024, with 14.56% growth. This brings the company's revenue in the last twelve months to 948.56M, up 8.64% year-over-year. In the fiscal year ending September 30, 2023, SCHOTT Pharma AG & Co. KGaA had annual revenue of 898.60M with 9.43% growth.
Revenue (ttm)
948.56M
Revenue Growth
+8.64%
P/S Ratio
4.23
Revenue / Employee
202.64K
Employees
4,646
Market Cap
4.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSCHOTT Pharma AG & Co. KGaA News
- 2 months ago - Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU” - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” - Wallstreet:Online
- 2 months ago - EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” - Wallstreet:Online